The objective of this cross-sectional study was to validate an abridged version of the Anosognosia Questionnaire—Dementia (AQ-D) for screening anosognosia in daily practice. The authors reduce the AQ-D from 30 items to 9, with a large sample (n = 352) of patients with Alzheimer disease (AD). The Cronbach α was .793 and an area under the receiver–operating characteristic curve was 0.946. The κ index between new abridged AQ-D (AAQ) and original AQ-D was .800. The AAQ presents good validity and reliability indicators and kept concordance with the original scale. It is quick and easy to administer and it can simplify the clinical screening of anosognosia in patients with AD.
OrfeiMDVarsiAEBlundoC. Anosognosia in mild cognitive impairment and mild Alzheimer's disease: frequency and neuropsychological correlates. Am J Geriatr Psychiat. 2010;18(12):1133–1140.
2.
MarkovaISBerriosGE. The ‘object' of insight assessment: relationship to insight ‘structure'. Psychopathology. 2001;34(5):245–252.
3.
ClareLWhitakerCJNelisSM. Multidimensional assessment of awareness in early-stage dementia: a cluster analytic approach. Dement Geriatr Cogn Disord. 2011;31(5):317–327.
4.
MichonADeweerBPillonBAgidYDuboisB. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J Neurol Neurosur Psych. 1994;57(7):805–809.
5.
BabinskiJ. Contribution à l'étude des troubles mentaux dans l'hémiplégie organique cérébrale (anosognosie). Rev Neurol (Paris). 1914;27:845–848.
6.
Ecklund-JohnsonETorresI. Unawareness of deficits in Alzheimer's disease and other dementias: operational definitions and empirical findings. Neuropsychol Rev. 2005;15(3):147–166.
7.
MedaliaAThysenJ. Insight into neurocognitive dysfunction in schizophrenia. Schizophr Bull. 2008;34(6):1221–1230.
8.
JenkinsonPMPrestonCEllisSJ. Unawareness after stroke: a review and practical guide to understanding, assessing, and managing anosognosia for hemiplegia. J Clin Exp Neuropsychol. 2011;33(10):1079–1093.
9.
LeichtHBerwigMGertzHJ. Anosognosia in Alzheimer's disease: the role of impairment levels in assessment of insight across domains. J Int Neuropsychol Soc. 2010;16(3):463–473.
10.
ClareL. The construction of awareness in early-stage Alzheimer's disease: a review of concepts and models. Br J Clin Psychol. 2004;43(pt 2):155–175.
11.
SpallettaGGirardiPCaltagironeCOrfeiMD. Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment. J Alzheimers Dis. 2012;29(4):761–772.
12.
Conde-SalaJLReñé-RamírezRTurró-GarrigaO. Clinical differences in patients with Alzheimer's disease according to the presence or absence of anosognosia: implications for perceived quality of life. J Alzheimers Dis. 2013;33(4):1105–1116.
13.
KashiwaYKitabayashiYNarumotoJNakamuraKUedaHFukuiK. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits. Psychiatry Clin Neurosci. 2005;59(6):697–704.
14.
StarksteinSEJorgeRMizrahiRAdrianJRobinsonRG. Insight and danger in Alzheimer's disease. Eur J Neurol. 2007;14(4):455–460.
15.
AaltenPvan ValenEde VugtMELousbergRJollesJVerheyFR. Awareness and behavioral problems in dementia patients: a prospective study. Int Psychogeriatr. 2006;18(1):3–17.
16.
Turro-GarrigaOGarre-OlmoJVilalta-FranchJConde-SalaJLde Gracia BlancoMLópez-PousaS. Burden associated with the presence of anosognosia in Alzheimer's disease. Int J Geriatr Psychiatry. 2013;28(3):291–297.
17.
ReedBRJagustWJCoulterL. Anosognosia in Alzheimer's disease: relationships to depression, cognitive function, and cerebral perfusion. J Clin Exp Neuropsychol. 1993;15(2):231–244.
18.
BisiachEVallarGPeraniDPapagnoCBertiA. Unawareness of disease following lesions of the right hemisphere: anosognosia for hemiplegia and anosognosia for hemianopia. Neuropsychologia. 1986;24(4):471–482.
19.
MigliorelliRTesónASabeL. Anosognosia in Alzheimer’s disease: a study of associated factors. J Neuropsychiatry Clin Neurosci. 1995;7(3):338–344.
20.
StarksteinSESabeLChemerinskiEJasonLLeiguardaR. Two domains of anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996;61(5):485–490.
21.
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944.
22.
FolsteinMFFolsteinSEMcHughPR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
23.
GelinasIGauthierLMcIntyreMGauthierS. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999;53(5):471–481.
24.
CummingsJLMegaMGrayKRosenberg-ThompsonSCarusiDAGornbeinJ. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–2314.
25.
ReisbergBFerrisSHde LeonMJCrookT. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–1139.
26.
KimJOMuellerCW. Construction of Factors Scales. Statistical methods and practical issues. In: JohnF, ed. Series on Quantitative Applications in the Social Sciences. Beverly Hills, CA: Sage University Paper; 1978:60–72.
27.
ArkinSMahendraN. Insight in Alzheimer's patients: results of a longitudinal study using three assessment methods. Am J Alzheimers Dis Other Dement. 2001;16(4):211–224.
28.
AnsellELBucksRS. Mnemonic anosognosia in Alzheimer's disease: a test of Agnew and Morris (1998). Neuropsychologia. 2006;44(7):1095–1102.
29.
HannesdottirKMorrisRG. Primary and secondary anosognosia for memory impairment in patients with Alzheimer's disease. Cortex. 2007;43(7):1020–1030.
30.
AgnewSMorrisR. The heterogeneity of anosognosia for memory impairment in Alzheimer's disease: a review of the literature and a proposed model. Aging Ment Health. 1998;2(1):7–19.
31.
ClareLMarkovaIVerheyFKennyG. Awareness in dementia: a review of assessment methods and measures. Aging Ment Health. 2005;9(5):394–413.
32.
SatoJNakaakiSMurataY. Two dimensions of anosognosia in patients with Alzheimer's disease: reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D). Psychiatry Clin Neurosci. 2007;61(6):672–677.
33.
BlessedGTomlinsonBERothM. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797–811.
34.
VasterlingJJSeltzerBWatrousWE. Longitudinal assessment of deficit unawareness in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10(3):197–202.
35.
BedardMMolloyDWSquireLDuboisSLeverJAO'DonnellM. The Zarit burden interview: a new short version and screening version. Gerontologist. 2001;41(5):652–657.
36.
KauferDICummingsJLKetchelP. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–239.
37.
Ortega-OrcosRSalinero-FortMAKazemzadeh-KhajouiAVidal AparicioSde Dios del Valle R. Validation of 5 and 15 items Spanish version of the geriatric depression scale in elderly subjects in primary health care setting. Rev Clin Esp. 2007;207(11):559–562.
38.
SheikhJIYesavageJA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165–172.
39.
BanerjeeSWittenbergR. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. Int J Geriatr Psychiatry. 2009;24(7):748–754.
